Literature DB >> 21273945

Pores of the inner limiting membrane in flat-mounted surgical specimens.

Arnd Gandorfer1, Ricarda Schumann, Renate Scheler, Christos Haritoglou, Anselm Kampik.   

Abstract

PURPOSE: To demonstrate the incidence of pores in the inner limiting membrane (ILM) in flat-mounted ILM specimens and to show the immunocytochemical properties of cellular proliferation associated with them.
METHODS: One hundred and twelve ILM specimens from patients with idiopathic macular holes were flat mounted and screened for pores. The ILM was assessed by phase-contrast and interference microscopy. Various antibodies were used against glial cells, hyalocytes, and retinal pigment epithelial cells.
RESULTS: In total, only three pores were found. They were characterized by a full-thickness defect of the ILM with irregular borders and cellular proliferation on the ILM. Glial cells were seen in direct association with the ILM pore. Glial cell and hyalocyte markers were the main immunologic features observed.
CONCLUSION: Inner limiting membrane pores are a rare finding. Glial cells are likely to cross the ILM through these pores on their way from the retina to the vitreoretinal border. Given the frequency of cellular proliferation and the rare finding of ILM pores, other pathways have to be considered in playing the leading role in epiretinal proliferation. They might include migration of cells through ILM thinning along retinal vessels and proliferation of vitreous cortex hyalocytes at the vitreoretinal border.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273945     DOI: 10.1097/IAE.0b013e3181f44282

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  Hyalocytes in idiopathic epiretinal membranes: a correlative light and electron microscopic study.

Authors:  Ricarda G Schumann; Arnd Gandorfer; Jean Ziada; Renate Scheler; Markus M Schaumberger; Armin Wolf; Anselm Kampik; Christos Haritoglou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-07       Impact factor: 3.117

2.  [Importance of morphological and functional diagnostics of the vitreoretinal interface].

Authors:  W J Mayer; R G Schumann; A Kampik; C Haritoglou
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

Review 3.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

4.  Comparison of histopathological findings between idiopathic and secondary epiretinal membranes.

Authors:  Mari Ueki; Seita Morishita; Ryohsuke Kohmoto; Masanori Fukumoto; Hiroyuki Suzuki; Takaki Sato; Takatoshi Kobayashi; Teruyo Kida; Hidehiro Oku; Tsunehiko Ikeda; Yuro Shibayama
Journal:  Int Ophthalmol       Date:  2016-02-08       Impact factor: 2.031

5.  Effect of vitrectomy with silicone oil tamponade and internal limiting membrane peeling on eyes with proliferative diabetic retinopathy.

Authors:  Sung Yeon Jun; Daniel Duck-Jin Hwang
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

6.  [Epiretinal gliosis].

Authors:  C Haritoglou; R G Schumann; A Wolf
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

7.  Vital dyes increase the rigidity of the internal limiting membrane.

Authors:  C Haritoglou; S Mauell; M Benoit; R G Schumann; P B Henrich; A Wolf; A Kampik
Journal:  Eye (Lond)       Date:  2013-08-16       Impact factor: 3.775

Review 8.  Epiretinal membrane: optical coherence tomography-based diagnosis and classification.

Authors:  William Stevenson; Claudia M Prospero Ponce; Daniel R Agarwal; Rachel Gelman; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-29

9.  Vitrectomy for the removal of idiopathic epiretinal membrane with or without internal limiting membrane peeling: a meta-analysis.

Authors:  Eleni Christodoulou; Georgios Batsos; Petros Galanis; Christos Kalogeropoulos; Andreas Katsanos; Yannis Alamanos; Maria Stefaniotou
Journal:  Ther Adv Ophthalmol       Date:  2020-08-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.